The hidden crisis in regenerative medicine
Dr Tommy Rhee, CEO of RheeGen, outlines how FDA crackdowns have revealed dangerous and unethical tissue sourcing practices: Two decades…
18 Nov 2025
FDA inspection reveals critical supply chain vulnerabilities
When US Food and Drug Administration (FDA) inspectors arrived unannounced at Hetero Labs' warehouse facility in Visakhapatnam, India, on 19 September , they documented conditions that would result in a…
18 Nov 2025
Real-time data: how to gain an edge amid clinical services consolidation
The pharmaceutical services industry is undergoing both innovation and consolidation – trends that are redefining competition and opening new strategic fronts for clinical technology vendors and contract research organizations (CROs).…
29 Sep 2025
The dangerous second life of medical waste
Beyond the more apparent environmental challenges of rising medical waste from at-home injectables like Glucagon-like peptide-1 (GLP-1) agonists, pharmaceutical companies are grappling with a quieter but equally urgent issue: the…
29 Apr 2024
BIOSECURE bill targets more Chinese companies as biotechs and their customers adapt to defunding
US lawmakers have added more Chinese biotech and medtech companies to the list of firms posing national security risks that they are seeking to prevent doing business with the US.…
21 Dec 2023
The curtain closes on a successful World Investment Conference in New Delhi
NEW DELHI – The World Investment Conference (WIC) 2023, the annual meeting of the World Association of Investment Promotion Agencies (WAIPA), has concluded in New Delhi after an action-packed four…
09 Nov 2023
Cloud in pharma: Q&A with GlobalData thematic analyst
Jemima Walker is a healthcare analyst in GlobalData’s Thematic Intelligence team. Her expertise lies in the healthcare industry and in themes including cloud, robotics, ecommerce, healthtech, and cybersecurity. Lara Virrey:…